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Pol II, which is uniquely responsible for synthesis of
spliced and polyadenylated mRNA, and pre-mRNA tran-
Eukaryotic cells must execute a complex program to scripts engineered to be synthesized by RNA polymer-
generate mature functional messenger RNA (mRNA). ase III in mammalian cells fail to be spliced (Sisodia et
After the transcription of a nuclear gene by RNA poly- al., 1987). Greenleaf (1993) proposed that the negative
merase II (RNA Pol II) is initiated, introns must be re- charge of the hyperphosphorylated CTD on RNA Pol
moved from the pre-mRNA and the mature 39 end of IIo might facilitate direct electrostatic interactions with
the transcript defined by specific cleavage and polyade- highly basic arginine±serine (RS) dipeptide repeat se-
nylation. Although the splicing and 39-end formation quences characteristic of many splicing factors in multi-
reactions can occur in isolation from transcription in cellular eukaryotes, including members of theSR protein
vitro, there have been periodic reminders that transcrip- family (reviewed by Fu, 1995). This prediction has proven
tion and pre-mRNA processing may be coupled in vivo. to be very close to the mark.
Electron microscopy and microdissection studies illus- Association of Pre-mRNA Splicing Factors
trate that splicing can occur cotranscriptionally (Beyer with the CTD
and Osheim, 1988; Wetterberg et al., 1996), and available Several groups have now established that SR proteins
evidence indicates that 39-end processing not only pre- and other spliceosome components are indeed physi-
cedes but also may be a prerequisite for termination of cally associated with RNA polymerase II. Antibodies
transcription (Connelly and Manley, 1988; Russo and specific for the RNA Pol II CTD have been found to
Sherman, 1989). However, factors or mechanisms that coimmunoprecipitate from mammalian cell extracts a
might couple mRNA processing to transcription have set of proteins reactive with anti-SR protein monoclonal
antibodies (Yuryev et al., 1996; Kim et al., 1997) as wellbeen elusive.
as spliceosomal snRNPs (Chabot et al., 1995; VincentRecent reports from a number of sources are begin-
et al., 1996). Reciprocal coprecipitation of RNA Pol II byning to fill in themissing pieces of thepuzzle. The striking
antibodies directed against SR proteins or against therevelation linking these studies is the finding that splic-
Sm antigens common to spliceosomal snRNPs furthering factors and the 39-end formation apparatus are con-
supports the existence of a bona fide complex (Mortil-nected to the transcriptional machinery through the car-
laro et al., 1996; Kim et al., 1997). Components of thisboxy-terminal domain, or CTD, of the largest subunit of
complex are not simply tethered to each other by na-RNA polymerase II. This physical association may en-
scent RNA, since the association of Pol II with SR andsure that the nascent transcript is presented directly to
Sm proteins is resistant to exhaustive ribonucleasethe pre-mRNA processing machinery even as its synthe-
treatment and is maintained during stages of the cellsis continues, and furthermore may enable coordinate
cycle when transcription does not occur (Kim et al.,regulation of transcription and processing. In order to
1997). Intermediates in the splicing reaction generatedconsider these implications, it is necessary first to touch
in vitro from exogenous pre-mRNA can be precipitatedbriefly on the role of the CTD and its reversible phosphor-
by anti-CTD antibodies, implying that functional spliceo-ylation in the transcription cycle, a subject of recent
somes associate with RNA Pol II even when it is notreviews (Koleske and Young, 1995; Dahmus, 1996).
transcriptionally engaged (Chabot et al., 1995; MortillaroThe CTD is a conserved and essential structure con-
et al., 1996).
sisting of a repeated heptapeptide with the consensus
RNA Pol IIo, the hyperphosphorylated form of the en-
sequence, YSPTSPS. Mouse has 52 tandem repeats,
zyme implicated in processive transcriptional elonga-
while the yeast S. cerevisiae has 26 or 27. Two forms tion, is preferentially associated with splicing com-
of RNA Pol II differing in the extent of phosphorylation plexes. This is evident in the coprecipitation of Pol IIo,
on the CTD can be distinguished and are thought to but not Pol IIa, by anti-SR and anti-Sm antibodies (Mor-
have distinct functions in the transcription cycle. RNA tillaro et al., 1996; Kim et al., 1997). Several lines of
Pol IIa, with a hypophosphorylated CTD, is the form evidence indicate that association with the RNA Pol IIo
that assembles into transcription initiation complexes. CTD is important for spliceosome function in vitro and
Interactions between the CTD of RNA Pol IIa and factors in vivo. Remarkably, in vitro splicing of exogenous pre-
that may facilitate initiation complex assembly have mRNA substrate can be inhibited by anti-CTD antibody
been examined as a possible mechanism for transcrip- or by CTD peptides (Yuryev et al., 1996). Excess pep-
tional activation. Coincident with or shortly after tran- tides or antibody may displace multiple splicing factors
scription initiation, the CTD becomes hyperphosphory- from the CTD, preventing their colocalization and thus
lated to generate the form of the enzyme known as RNA inhibiting spliceosome assembly. Interestingly, the sec-
Pol IIo. The precise role of CTD phosphorylation in the ond catalytic step of splicing appears to be inhibited
transcription cycle remains unclear, but it may convert at low peptide concentrations, while the first step is
the polymerase from a form prone to pausing or termina- inhibited only at higher peptide concentrations, consis-
tent with differential titration of factors required for thetion into a form capable of processive elongation. After
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first and second steps. Thus, the CTD may provide a arginine repeats. Representatives of one class, typified
platform for the recruitment and stepwise assembly of by the rat rA1 and rA9 proteins, share an 80-residue
spliceosome components. CTD-binding domain at their carboxyl termini. Direct
Splicing in vivo likewise is inhibited by expression of association of this domain with hyper- or minimally
polypeptides containing CTD repeats but lacking most phosphorylated yeast RNA Pol II has been demon-
of the rest of the RNA Pol II large subunit (Du and Warren, strated in vitro. A second class is defined by the rA4
1997). The recombinant CTD polypeptides are subject and rA8 proteins, which interact with the CTD in the
to phosphorylation and localize to the nucleus, where two-hybrid assay via an amino-terminal domain of z120
their presence results in dispersal of splicing factors residues. The latter proteins further resemble SR pro-
from discrete loci of concentration.Splicing is also inhib- teins and SR-related splicing factors in having an RNP-
ited when cells transfected with an a-amanitin-resistant, consensus RNA recognition motif (RRM).
CTD-truncated allele of the RNA Pol II large subunit The CTD-binding proteins identified by Yuryev et al.
are treated with the antibiotic, confining transcriptional (1996) are good candidates for some of the anti-SR reac-
activity to the truncated form of the polymerase tive factors identified in RNA Pol II immunoprecipitates
(McCracken et al., 1997). The simplest interpretation of and may connect spliceosomes to the CTD through pro-
these results is that spliceosomes must be associated tein±protein or RNA±protein interactions. However,
with transcriptionally engaged polymerase in order to while they bear strong resemblance to known splicing
catalyze efficient splicing in vivo. factors, a role for these proteins in splicing has not yet
Association of Cleavage/Polyadenylation been demonstrated. Thus, although these studies are
Factors with the CTD tantalizingly close to the identification of a connection
In vivo experiments employing a-amanitin-resistant between spliceosomes and the CTD, the circle has not
forms of RNA Pol II revealed that 39-end processing, been completely closed.
like pre-mRNA splicing, is inhibited when the trans- What About Yeast?
criptionally active polymerase lacks an intact CTD Although the splicing reaction mechanism and most of
(McCracken et al., 1997). Furthermore, cleavage stimula- the spliceosome's major components are well-con-
tory factor (CstF) and cleavage/polyadenylation speci- served, pre-mRNA splicing in yeast and mammalian
ficity factor (CPSF), but not poly(A) polymerase, are re- cells differs in several respects. Only about 4% of pro-
tained when HeLa cell extracts are chromatographed
tein-coding genes in S. cerevisiae have introns, and al-
on CTD-affinity columns. A similar profile of polyadenyl-
ternative splicing is virtually nonexistent. Splicing pro-
ation factors copurifies extensively with RNA Pol II
teins with RS domains, which play such pivotal roles in
through affinity and gel-filtration steps. Binding experi-
both constitutive and alternative splicing in multicellular
ments with in vitro±translated CstF subunits revealed
organisms, are very poorly represented in S. cerevisiae
that two of its three subunits are able to bind directly
and S. pombe. Genetic studies of CTD function in S.to immobilized CTD peptides. It is not yet known if bind-
cerevisiae suggest that its major cellular role is relateding of CPSF is direct or mediated through its association
to transcriptional activation, since growth defects duewith CstF.
to CTD truncation can be suppressed by mutations inThe finding that polyadenylation factors associate
transcription factors (Koleske and Young, 1995). Finally,with the CTD suggests an explanation for the depen-
the rule that transcripts synthesized by RNA Pol III aredence of transcription termination on functional 39-end
not spliced is violated by several different yeast speciesformation signals (Connelly and Manley, 1988) and for
that have mRNA-type introns within their RNA Pol III±the observation from the current study that termination
transcribed genes encoding the spliceosomal RNA U6in response to these signals also depends on an intact
(Tani and Ohshima, 1991).CTD. McCracken et al. (1997) propose that the recogni-
It is remarkable, therefore, that S. cerevisiae harbors ation of polyadenylation signals may alter the association
relative of the rA4/rA8 class of mammalian CTD-binding,of processing factors with the CTD, which may cause
SR-like proteins (Steinmetz and Brow, 1996). The yeastthe polymerase to switch to a termination-competent
Nrd1 protein has an amino-terminal domain with se-form. However, it remains equally possible that the act
quence similarity to the CTD-binding domains of rA4of cleavage itself, generating an uncapped 59 end, is
and rA8, and this region of Nrd1p was also found tothe primary event resulting in subsequent termination
interact weakly with nonconsensus repeats of the(Connelly and Manley, 1988). It should be possible now
mouse CTD in the two-hybrid assay (Yuryev et al., 1996).to design experiments to distinguish between these
Binding to the yeast CTD, which consists mostly of per-possibilities.
fect matches to the heptapeptide consensus, is inferredNovel CTD-Binding Proteins
but has not yet been demonstrated. Nrd1p also has aWhat molecules may connect spliceosomes to theCTD?
single RRM as well as a segment rich in RE and RSYuryev et al. (1996) used theyeast two-hybrid interaction
dipeptides, both situated in relative positions within thescreen to identify mammalian factors that bind to re-
protein's primary structure comparable to the corre-peats 36±52 of the mouse CTD, composed entirely of
sponding domains in the rA8 protein. Interestingly, ho-nonconsensus heptapeptides. Proteins of two novel
mology searches have identified an additional class ofclasses were recovered. Members of both classes con-
proteins conserved at least among S. cerevisiae, S.tain RS and RE dipeptide repeat domains resembling
pombe, and C. elegans that share a similar N-terminalthose found in SR proteins and other splicing factors, in
CTD-binding domain but have zinc-finger repeats inapparent support of the prediction by Greenleaf (1993).
place of the RRM and RE/RS domains found in the Nrd1,However, interaction with the CTD in each case is medi-
ated by a short domain distinct from the alternating rA4, and rA8 proteins.
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Figure 1. Schematic Representation of the
Associationof Pre-mRNA Processing Factors
with the Carboxy-Terminal Domain (CTD)
of Transcriptionally Engaged RNA Polymer-
ase II
Potential physical and functional interactions
between splicing, polyadenylation, and elon-
gation factors are indicated by double-
headed arrows.
Nrd1p mediates the severe decrease in synthesis of polymerase is not engaged in the synthesis of the splic-
ing substrate. At what point are spliceosomes releasedpre-mRNA that is caused by insertion of a complex se-
quence element into the intron of a reporter gene from the CTD in vivo? Do processing factors dissociate
from the CTD as they associate with nascent pre-mRNA,(Steinmetz and Brow, 1996). This effect can be over-
come by substitution of a single amino acid in the Nrd1p or might a polymerase molecule be committed to its
newly synthesized pre-mRNA transcript until processingRRM or by point mutations clustered within the se-
quence element, suggesting that binding of Nrd1p to the is complete, even after transcription has terminated?
Can multiple spliceosomes assemble on a single CTDsequence element is required to decrease pre-mRNA
synthesis. A likely mechanism for Nrd1p action is simultaneously, or must each intron be spliced in suc-
cession? What might be the significance for alternativethrough control of transcript elongation, since truncated
transcripts having 39 ends just downstream of the se- splicing? Might microheterogeneous control of CTD
phosphorylation and, thereby, factor binding play a rolequence element accumulate in place of full-length pre-
mRNA. Disruption of the NRD1 gene is lethal, but the in splicing regulation? The answers to these questions
will require detailed characterization of the molecularamino-terminal portion of the protein containing the
CTD-binding domain is sufficient for viability, suggesting connections between the spliceosome and the CTD and
dissection of the precise role of the CTD in spliceosomethat interactions with the CTD may serve an essential
function. Modulation of this function through interac- assembly and function.
It isattractive toconsider the mRNA factory as a highlytions at Nrd1p's RNA-binding domain may lead to tran-
scriptional pausing or termination. The apparent conser- integrated machine. For example, intercommunication
between splicing and polyadenylation factors (e.g., Lutzvation of this CTD-binding domain is intriguing, and it
will be of interest to learn whether any of the related et al., 1996), facilitated by their colocalization, may allow
the coordinated selection of splice junctions and cleav-CTD-binding factors might have a similar capacity to
mediate control of pre-mRNA synthesis. age/polyadenylation sites. The apparent role of the CTD
in transcriptional activation raises the possibility thatImplications
The studies described herein foster an expanded view the specificity or efficiency of processing may be deter-
mined in part by promoter-specific factors, or that asso-of cellular functions of the CTD of RNA polymerase II.
The biogenesis of mRNA in mammalian cells can now ciation with processing factors in turn may influence
initiation. Promoter-dependent selection of snRNA ver-be seen as a set of coordinated processes (see Figure
1), with the CTD participating not only in the activation sus mRNA 39-end formation pathways (Dahlberg and
Lund, 1988), for example, conceivably could be medi-of transcription, but also as the foundation of an ªRNA
factoryº (McCracken et al., 1997). At the level of resolu- ated by CTD-bound factors. Accumulating evidence im-
plicates the CTD as a target for control of transcriptionaltion afforded by currently available data, it cannot be
discerned whether this factory comprises an ordered elongation, whether through modulation of its phos-
phorylation state or its association with specific factors.assembly line or simply provides the necessary pro-
cessing machinery in proximity to the site of RNA syn- An exciting corollary is that signals from the processing
machinery may be propagated through the CTD to coor-thesis. In either case, the localization of this machinery
may have significant ramifications for regulation of gene dinate the continued elongation of a transcript with its
processing, providing a form of mRNA surveillance orexpression.
Although splicing in vivo can occur cotranscription- ªquality control.º Such a mechanism could lie at the
heart of the observed coupling between 39-end pro-ally, this is not obligatory since some introns are not
removed until after the RNA has been released from cessing and transcript termination, as proposed by
McCracken et al. (1997). A similar coupling mechanismthe chromosome (Wetterberg et al., 1996). Yet in vitro
studies suggest that association with the CTD is main- could signal pausing or termination of transcription in
response to delays or errors in spliceosome assembly ortained during the catalytic steps of splicing even when
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function. These signals might be relayed through factors
like the yeast Nrd1 protein or related mammalian SR-
like proteins. Clearly, researchers investigating RNA Pol
II transcription and those studying pre-mRNA pro-
cessing will both contribute to this unfolding picture.
With their combined efforts, a ``grand unified theory'' of
mRNA biogenesis may soon be at hand.
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